Pharmaceutical Good Manufacturing Practice Regulations Article 36

Chinese herbal medicine factories shall establish in writing management procedures for the acceptance, labeling, storage, handling, sampling and testing of packaging and labeling materials.Where over-the-counter drug products for human use are produced, packaging for aforesaid products shall be tamper-proof, and shall be kept intact during the manufacturing, shipping and retail display process; moreover, aforesaid packaging shall be designed in such a manner that tampering is easily detectable by consumers.Prior to the acceptance or use of labeling and packaging materials, representative samples shall be taken from each batch for testing; testing results shall be recorded and samples preserved. Where test results comply with established specifications, aforesaid materials may be approved for use; where aforesaid materials are not in compliance, they shall not be approved for use.
中文原文 藥物優良製造準則第36條
中藥廠對於包裝材料與標示材料之驗收、標識、儲存、管理、取樣及檢驗,應訂定書面管制作業程序。
生產人用成藥,應有防止摻偽包裝之設計,並在製造、運送及零售陳列中,得以保持完整,且於有異常情形時,使消費者能易於辨識。
標示材料或包裝材料於驗收或使用前,應逐批抽取具代表性之樣品予以檢驗,記錄其結果,並予保存。
檢驗結果符合既定規格者,始予准用;不符者,應予拒用。

English translation for reference only; the Chinese text prevails. Not legal advice.